fluconazole has been researched along with Bile Duct Obstruction in 6 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although a fluconazole prophylaxis regimen for ELBW infants was effective in preventing invasive candidiasis, an increase in the incidence of conjugated hyperbilirubinemia was observed." | 7.73 | Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. ( Aghai, ZH; Amendolia, B; Kaki, S; Kemble, N; Longo, D; Mudduluru, M; Nakhla, TA; Saslow, JG; Stahl, GE; Sutsko, R, 2006) |
| " The authors previously reported an increased incidence of cholestasis with fluconazole prophylaxis in ELBW infants, which led to fluconazole prophylaxis being changed to a less frequent dosing (LFD) schedule of twice a week at their institution." | 6.76 | Twice-weekly fluconazole prophylaxis in premature infants: association with cholestasis. ( Aghai, ZH; Amendolia, B; Bhat, V; Fojas, M; Kemble, N; Pyon, K; Sannoh, S; Saslow, JG; Shah, S; Stahl, G, 2011) |
| "Prophylactic fluconazole reduces the incidence of colonization and invasive candida infection in neonates weighing less than 1500 g at birth." | 5.12 | A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. ( Arisio, R; Corona, G; Decembrino, L; Farina, D; Giovannozzi, C; Gomirato, G; Magnani, C; Manzoni, P; Maule, M; Merletti, F; Mosca, F; Mostert, M; Pedicino, R; Pugni, L; Stolfi, I; Stronati, M; Tridapalli, E; Vetrano, G, 2007) |
| "Although a fluconazole prophylaxis regimen for ELBW infants was effective in preventing invasive candidiasis, an increase in the incidence of conjugated hyperbilirubinemia was observed." | 3.73 | Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. ( Aghai, ZH; Amendolia, B; Kaki, S; Kemble, N; Longo, D; Mudduluru, M; Nakhla, TA; Saslow, JG; Stahl, GE; Sutsko, R, 2006) |
| " The authors previously reported an increased incidence of cholestasis with fluconazole prophylaxis in ELBW infants, which led to fluconazole prophylaxis being changed to a less frequent dosing (LFD) schedule of twice a week at their institution." | 2.76 | Twice-weekly fluconazole prophylaxis in premature infants: association with cholestasis. ( Aghai, ZH; Amendolia, B; Bhat, V; Fojas, M; Kemble, N; Pyon, K; Sannoh, S; Saslow, JG; Shah, S; Stahl, G, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satrom, K | 1 |
| Gourley, G | 1 |
| Aziz, M | 1 |
| Patel, AL | 1 |
| Losavio, J | 1 |
| Iyengar, A | 1 |
| Berven, M | 1 |
| Schloemer, N | 1 |
| Jakubowicz, A | 1 |
| Mathai, T | 1 |
| McAuley, JB | 1 |
| Bhat, V | 1 |
| Fojas, M | 1 |
| Saslow, JG | 2 |
| Shah, S | 1 |
| Sannoh, S | 1 |
| Amendolia, B | 2 |
| Pyon, K | 1 |
| Kemble, N | 2 |
| Stahl, G | 1 |
| Aghai, ZH | 2 |
| Mudduluru, M | 1 |
| Nakhla, TA | 1 |
| Longo, D | 1 |
| Kaki, S | 1 |
| Sutsko, R | 1 |
| Stahl, GE | 1 |
| Manzoni, P | 1 |
| Stolfi, I | 1 |
| Pugni, L | 1 |
| Decembrino, L | 1 |
| Magnani, C | 1 |
| Vetrano, G | 1 |
| Tridapalli, E | 1 |
| Corona, G | 1 |
| Giovannozzi, C | 1 |
| Farina, D | 1 |
| Arisio, R | 1 |
| Merletti, F | 1 |
| Maule, M | 1 |
| Mosca, F | 1 |
| Pedicino, R | 1 |
| Stronati, M | 1 |
| Mostert, M | 1 |
| Gomirato, G | 1 |
| Ramirez, FC | 1 |
| Walker, GJ | 1 |
| Sanowski, RA | 1 |
| Manne, RK | 1 |
| Stone, HH | 1 |
1 review available for fluconazole and Bile Duct Obstruction
| Article | Year |
|---|---|
Cholestasis in Preterm Infants.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Cholestasis; Enteral Nutrition; Enterocoli | 2016 |
2 trials available for fluconazole and Bile Duct Obstruction
| Article | Year |
|---|---|
Twice-weekly fluconazole prophylaxis in premature infants: association with cholestasis.
Topics: Antifungal Agents; Candidiasis, Invasive; Cholestasis; Drug Administration Schedule; Female; Flucona | 2011 |
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
Topics: Antifungal Agents; Candida; Candidiasis; Cholestasis; Double-Blind Method; Female; Fluconazole; Huma | 2007 |
3 other studies available for fluconazole and Bile Duct Obstruction
| Article | Year |
|---|---|
Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cholestasis; Female; Fluconazole; Humans; In | 2010 |
Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
Topics: Alkaline Phosphatase; Antibiotic Prophylaxis; Antifungal Agents; Bilirubin; Candidiasis; Case-Contro | 2006 |
Obstructive jaundice due to Coccidioides immitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Cholangiography; Cholangiopancreatography, Endosco | 1996 |